Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | FURIN | P09958 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9304772 | 0.98 | SLC6A4 (0.58) | SLC6A4SLC6A2SLC6A3PARP10HPGD | |
| SCHEMBL9913919 | 0.93 | SLC6A4 (0.58) | SLC6A4SLC6A2SLC6A3PARP10ALDH1A1 | |
| SCHEMBL2242868 | 0.89 | PARP10 (0.55) | PARP10HPGDALDH1A1TSHRGRM2 | |
| SCHEMBL623629 | 0.80 | PARP10 (0.53) | PARP10HPGDALDH1A1TSHRGRM2 | |
| SCHEMBL187857 | 0.79 | HRH1 (0.66) | SLC6A4SLC6A2SLC6A3HRH3 | |
| SCHEMBL15573563 | 0.79 | SLC6A4 (0.53) | SLC6A4SLC6A2SLC6A3PARP10HSD11B1 | |
| SCHEMBL16838813 | 0.79 | SLC6A4 (0.53) | SLC6A4SLC6A2SLC6A3HSD11B1SMN1; SMN2 | |
| SCHEMBL13478355 | 0.79 | SLC6A4 (0.53) | SLC6A4SLC6A2SLC6A3PARP10HSD11B1 | |
| SCHEMBL3115435 | 0.79 | SLC6A4 (0.53) | SLC6A4SLC6A2SLC6A3HSD11B1EPHX2 | |
| SCHEMBL257928 | 0.78 | EGFR (0.48) | PARP10HPGDALDH1A1TSHRGRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594669-B | Parallel ring derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-115594669-A | Fused ring derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-111712549-A | Controlled release antifouling coating composition via biocide interaction | 汉伯公司 | 2020-09-25 | — | — | CN | disclosed |
| CN-111263793-A | Self-polishing antifouling coating composition containing alkoxysilane | 汉伯公司 | 2020-06-09 | — | — | CN | disclosed |
| EP-2881384-B1 | PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAISHO PHARMACEUTICAL CO LTD (JP) | 2018-05-30 | — | — | EP | disclosed |
| US-20150175541-A1 | PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2015-06-25 | — | — | US | disclosed |
| US-20150175541-A1 | PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | TAISHO PHARMACEUTICAL CO., LTD (JP) | 2015-06-25 | — | — | US | disclosed |
| US-5298569-A | Time release agent polymers with main and side chains | NIPPON PAINT CO. (JP) | 1994-03-29 | — | — | US | disclosed |
| EP-0286243-B1 | Disintegration type resin particles, its preparation and coating composition containing the same | NIPPON PAINT CO LTD (JP) | 1993-11-03 | — | — | EP | disclosed |
| EP-0220965-B1 | RESINOUS COMPOSITION CAPABLE OF RELEASING A BIOACTIVE SUBSTANCE AT A CONTROLLED RATE | Nippon Paint Co., Ltd. (JP) | 1992-01-22 | — | — | EP | disclosed |
| US-4910234-A | Crosslinked resin particles containing ester, sulfonate, phosphonate or phosphate groups | NIPPON PAINT CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| EP-0286243-A1 | Disintegration type resin particles, its preparation and coating composition containing the same | Nippon Paint Co., Ltd. (JP) | 1988-10-12 | — | — | EP | disclosed |
| EP-0220965-A2 | Resinous composition capable of releasing a bioactive substance at a controlled rate | Nippon Paint Co., Ltd. (JP) | 1987-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150175541-A1 | PARTIALLY SATURATED NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | EGLN2, EGLN3, EGLN1 | SLC6A4 1083/4885SLC6A2 1975/4885SLC6A3 3037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.